| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide binding | HLA-DOA HLA-DQA1 NUP58 ITGAM AP2M1 LILRB5 CACNA1A CACNA1B LILRB3 RANBP6 NUP214 GRIN2B ADNP | 7.25e-05 | 318 | 226 | 13 | GO:0042277 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.14e-04 | 9 | 226 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.14e-04 | 9 | 226 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.68e-04 | 25 | 226 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | IgM binding | 2.21e-04 | 11 | 226 | 3 | GO:0001791 | |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 2.92e-04 | 12 | 226 | 3 | GO:0032396 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | RASSF2 HIPK1 CDS2 LRRK2 STYK1 JAK1 PARP4 XYLB PKN3 FLT3 TUT7 HIPK2 LRRK1 SIRT6 TEK CIT MKNK1 PALS1 IGF2R MTOR PRKCH POLQ MVK | 4.25e-04 | 938 | 226 | 23 | GO:0016772 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.75e-04 | 14 | 226 | 3 | GO:0008331 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 1.02e-04 | 9 | 228 | 3 | GO:0032998 | |
| Domain | VWF_A | 2.23e-05 | 99 | 220 | 8 | IPR002035 | |
| Domain | Ca_chan_IQ | 5.45e-05 | 7 | 220 | 3 | SM01062 | |
| Domain | GPHH_dom | 5.45e-05 | 7 | 220 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 5.45e-05 | 7 | 220 | 3 | PF08763 | |
| Domain | VDCC_a1su_IQ | 5.45e-05 | 7 | 220 | 3 | IPR014873 | |
| Domain | GPHH | 5.45e-05 | 7 | 220 | 3 | PF16905 | |
| Domain | COR | 1.38e-04 | 2 | 220 | 2 | IPR032171 | |
| Domain | COR | 1.38e-04 | 2 | 220 | 2 | PF16095 | |
| Domain | VDCCAlpha1 | 1.82e-04 | 10 | 220 | 3 | IPR002077 | |
| Domain | - | 3.13e-04 | 222 | 220 | 10 | 1.25.10.10 | |
| Domain | ARM-like | LRRK2 CUL7 PSME4 MN1 RANBP6 ECPAS ATAD2 IPO9 MTOR MROH2B LRBA | 3.73e-04 | 270 | 220 | 11 | IPR011989 |
| Domain | Cat_AA_permease | 4.11e-04 | 3 | 220 | 2 | IPR004755 | |
| Domain | VWFA | 4.15e-04 | 82 | 220 | 6 | PS50234 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 1.72e-05 | 30 | 155 | 5 | M47752 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.31e-05 | 36 | 155 | 5 | M26974 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 8.20e-05 | 41 | 155 | 5 | M29574 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.04e-04 | 43 | 155 | 5 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.04e-04 | 43 | 155 | 5 | M26975 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 1.59e-04 | 47 | 155 | 5 | M19708 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.02e-04 | 11 | 155 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.02e-04 | 11 | 155 | 3 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.02e-04 | 11 | 155 | 3 | M47958 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.14e-04 | 50 | 155 | 5 | MM14610 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.83e-04 | 53 | 155 | 5 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 3.09e-04 | 54 | 155 | 5 | M29594 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.36e-04 | 55 | 155 | 5 | MM14917 | |
| Pubmed | HIVEP2 HIPK1 SYNPO NUP58 ERBIN HSPA5 EHBP1 WASL ABI3BP HIPK2 NUP214 NCKAP5L MKNK1 TGFB1 ATF6 SH2D4A PRKCH KDM2A DUSP10 ZNF839 CUX1 | 1.50e-11 | 486 | 230 | 21 | 20936779 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAPGEF6 HIVEP2 VWA8 C19orf47 PSME4 RBM19 DENND5A ARHGAP21 PKN3 PHF12 LAD1 SOCS3 ICE1 NUP214 LRRK1 ATP13A2 CIT SLC7A1 CELSR1 IGF2R MTOR TTLL4 NUP188 LRBA SLC45A1 ZNF839 | 2.55e-08 | 1105 | 230 | 26 | 35748872 |
| Pubmed | ILF2 TBL1Y ZNF318 CUL7 GMEB2 ERBIN RNF214 AP2M1 GSE1 NFRKB PRPF19 NCOA2 KAT5 PHF12 COX5B HIPK2 NUP214 MAP7 MORC2 ADNP CIT PALS1 PABPN1 TADA2B SMARCA2 MTR CCAR1 LTV1 CUX1 DCP1A | 2.57e-08 | 1429 | 230 | 30 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 KDM3A RAPGEF6 ZNF318 ERBIN GSE1 EIF2B5 NFRKB MN1 RNF169 PHF12 YTHDC2 NUP214 MORC2 ECPAS ATAD2 SH2D4A SMARCA2 CCAR1 OGA DCP1A | 5.84e-08 | 774 | 230 | 21 | 15302935 |
| Pubmed | KDM3A VWA8 SYNPO NUP58 GMEB2 ANKLE2 PSME4 PHF12 ICE1 LRRK1 ECPAS ADNP ZNF532 TTLL4 NUP188 OGA NDRG4 | 1.07e-07 | 529 | 230 | 17 | 14621295 | |
| Pubmed | ILF2 IQGAP2 TBL1Y SYNPO ZNF318 ERBIN RTN1 SYNGAP1 ARHGAP21 SEC23A NCOA2 CACNA1A CACNA1E GRIN2B ADNP CIT PALS1 IGF2R MTOR CCAR1 EML1 CDH2 CUX1 | 1.32e-07 | 963 | 230 | 23 | 28671696 | |
| Pubmed | KDM3A HIVEP2 HIPK1 NCBP1 SYNPO NUP58 SYNGAP1 PLEKHH1 JAK1 AP2M1 ZNF624 HSPA5 ARHGAP21 PLXNB3 NCOA2 WASL FN1 ACOT1 GRIN2B CBR1 CIT ATF6 ZNF532 ASPA CCAR1 LRBA CUX1 | 1.34e-07 | 1285 | 230 | 27 | 35914814 | |
| Pubmed | KCNH7 ILF2 LACTB PLEKHH1 PSME4 ACSL6 RNF213 ECPAS IPO9 MTOR SMARCA2 LRBA CDH2 | 1.42e-07 | 304 | 230 | 13 | 32235678 | |
| Pubmed | RAPGEF6 ZNF318 GSE1 ARHGAP21 EHBP1 LCORL PHF12 ICE1 NUP214 ECPAS ADNP ZNF532 LRBA CUX1 DCP1A | 1.51e-07 | 418 | 230 | 15 | 34709266 | |
| Pubmed | 2.85e-07 | 3 | 230 | 3 | 38996073 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 2.85e-07 | 3 | 230 | 3 | 24523520 | |
| Pubmed | KDM3A PDE3B ILF2 ABI3 HLA-DQA1 CDS2 ANKLE2 PARP4 RBM19 ALDH16A1 PRPF19 HSPA5 EIF4H DERL2 RNF213 ECPAS CIT SLC7A1 IPO9 IGF2R MTOR NUP188 LRBA OGA DCP1A | 2.87e-07 | 1168 | 230 | 25 | 19946888 | |
| Pubmed | 2.90e-07 | 41 | 230 | 6 | 8724849 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | IQGAP2 ERBIN ITGB6 AP2M1 ARHGAP21 EHBP1 WASL RAB11FIP1 ATAD2 SLC7A1 PALS1 SLC7A2 SH2D4A IGF2R MTOR LRBA VPS13B | 2.97e-07 | 569 | 230 | 17 | 30639242 |
| Pubmed | 4.65e-07 | 24 | 230 | 5 | 25009997 | ||
| Pubmed | HIPK1 RIMS3 CDS2 SYNPO RTN1 SYNGAP1 CACNA1A CACNA1B CACNA1E STXBP5 GRIN2B CIT NDRG4 | 6.38e-07 | 347 | 230 | 13 | 17114649 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ILF2 ABI3 CDIN1 NFRKB CACNA1A CACNA1B CACNA1E FN1 RPP30 YTHDC2 NUP214 MORC2 TENM4 LRRC8B DCP1A | 7.58e-07 | 475 | 230 | 15 | 31040226 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | VWA8 CDS2 ZNF318 NUP58 AP2M1 EIF4H TUT7 YTHDC2 NUP214 MAP7 ECPAS CIT SLC30A7 IGF2R PABPN1 MTOR CCAR1 CUX1 DCP1A | 7.77e-07 | 754 | 230 | 19 | 33060197 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SCFD2 PDE3B ILF2 VWA8 CUL7 ANKLE2 CHRM2 RTN1 LACTB ALDH1L2 SEC23A EHBP1 COL15A1 COX5B TUT7 RANBP6 RNF213 YTHDC2 ACOT1 GFM2 NUP35 ATF6 PEBP1 MTR PRKCH NUP188 VPS13B CUX1 | 7.86e-07 | 1496 | 230 | 28 | 32877691 |
| Pubmed | FILIP1 RBM19 HSPA5 RNF213 YTHDC2 NUP214 NUP35 SMARCA2 CCAR1 KDM2A POLQ | 9.98e-07 | 250 | 230 | 11 | 33536335 | |
| Pubmed | RAPGEF6 ILF2 IQGAP2 CDS2 ZNF318 ANKLE2 ERBIN PSME4 ALDH1L2 TMEM106C NFRKB ARHGAP21 NCOA2 FN1 TUT7 HIPK2 SLC7A1 IGF2R INTS13 TTLL4 NUP188 VPS13B DCP1A | 1.02e-06 | 1084 | 230 | 23 | 11544199 | |
| Pubmed | IREB2 RRM2 ANKLE2 ERBIN AP2M1 ALDH16A1 HSPA5 EHBP1 EIF4H STXBP5 ACOT1 NUP214 RAB11FIP1 CBR1 NUP35 TGFB1 SLC30A7 IGF2R CCAR1 LTV1 LRBA DCP1A | 1.11e-06 | 1007 | 230 | 22 | 34597346 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 1.14e-06 | 4 | 230 | 3 | 32616470 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 1.14e-06 | 4 | 230 | 3 | 37141091 | |
| Pubmed | KDM3A ILF2 ZNF318 GMEB2 AP2M1 GSE1 NFRKB PRPF19 NCOA2 EIF4H LCORL PHF12 RPP30 MORC2 ECPAS ADNP CIT LSM6 PEBP1 SMARCA2 CCAR1 CUX1 MVK | 1.37e-06 | 1103 | 230 | 23 | 34189442 | |
| Pubmed | PDE3B IQGAP2 ANKLE2 AP2M1 HSPA5 SEC23A DERL2 ACOT1 RAB11FIP1 CBR1 NUP35 SLC30A7 TMX2 SLC7A1 PALS1 ATF6 SLC7A2 IGF2R PRKCH LRBA CUX1 | 1.69e-06 | 952 | 230 | 21 | 38569033 | |
| Pubmed | HIVEP2 CUL7 PKD1L2 PSME4 HSPA5 CACNA1B FN1 CIT TMX2 IPO9 PRKCH CDH13 | 1.83e-06 | 322 | 230 | 12 | 26514267 | |
| Pubmed | ILF2 NCBP1 ZNF318 CUL7 SEC23A FN1 TUT7 YTHDC2 NUP214 ECPAS ADNP ATAD2 IGF2R MTOR SMARCA2 CCAR1 NUP188 | 1.95e-06 | 653 | 230 | 17 | 22586326 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PDE3B HIVEP2 SYNPO ERBIN PLEKHH1 BTG2 XYLB DENND5A NCOA2 EHBP1 HIPK2 RNF213 ECPAS DNAH1 TATDN3 SLC7A1 ATF6 ZNF532 TSPAN10 SMARCA2 CCAR1 KDM2A LRBA ZNF839 CATSPERG VPS13B CUX1 | 2.28e-06 | 1489 | 230 | 27 | 28611215 |
| Pubmed | 2.83e-06 | 5 | 230 | 3 | 8825650 | ||
| Pubmed | 2.83e-06 | 5 | 230 | 3 | 16260650 | ||
| Pubmed | 2.83e-06 | 5 | 230 | 3 | 11296258 | ||
| Pubmed | 2.83e-06 | 5 | 230 | 3 | 15451373 | ||
| Pubmed | KDM3A ILF2 C19orf47 ZNF318 GSE1 NFRKB PRPF19 RNF169 KAT5 ADNP TADA2B OGA | 3.11e-06 | 339 | 230 | 12 | 30415952 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ERBIN FBXL6 JAK1 GSE1 EIF2B5 RPP30 RNF213 ECPAS ADNP KDM2A NUP188 DCP1A | 3.30e-06 | 341 | 230 | 12 | 32971831 |
| Pubmed | HIPK1 RIMS3 ERBIN PLEKHH1 GSE1 ARHGAP21 PLXNB3 ACSL6 EIF4H STXBP5 NUP214 TENM4 VPS13B | 3.71e-06 | 407 | 230 | 13 | 12693553 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ILF2 RRM2 ERBIN AP2M1 PSME4 RBM19 EIF2B5 PRPF19 HSPA5 SEC23A FN1 EIF4H TUT7 RPP30 NUP214 ADNP ATAD2 CBR1 IPO9 PABPN1 SMARCA2 CCAR1 KDM2A LTV1 DCP1A | 4.01e-06 | 1353 | 230 | 25 | 29467282 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPGEF6 ZNF318 ERBIN RTN1 AP2M1 GSE1 PRPF19 ARHGAP21 PKN3 EHBP1 EIF4H YTHDC2 ICE1 NUP214 ADNP PEBP1 LTV1 LRBA OGA DCP1A | 4.68e-06 | 934 | 230 | 20 | 33916271 |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 5.63e-06 | 6 | 230 | 3 | 12827191 | |
| Pubmed | 5.63e-06 | 6 | 230 | 3 | 9238069 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 5.63e-06 | 6 | 230 | 3 | 35324301 | |
| Pubmed | SCFD2 CDS2 PLEKHH1 PARP4 GSE1 NCOA2 MXRA5 PHF12 COX5B DERL2 IPO9 INTS13 ASXL3 SMARCA2 LTV1 CUX1 | 6.29e-06 | 638 | 230 | 16 | 31182584 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | CDS2 IREB2 NCBP1 JAK1 ARHGAP21 EHBP1 WASL STXBP5 DERL2 ACOT1 RAB11FIP1 CBR1 NUP35 PALS1 IGF2R LRBA CDH2 | 6.96e-06 | 719 | 230 | 17 | 35337019 |
| Pubmed | TBL1Y ZNF318 ERBIN FBXL6 RBM19 NFRKB RNF169 KAT5 PHF12 COX5B RPP30 YTHDC2 ICE1 MAP7 RAB11FIP1 MORC2 ATAD2 CIT NUP35 SLC30A7 TMX2 CELSR1 INTS13 TADA2B SMARCA2 CCAR1 | 7.64e-06 | 1497 | 230 | 26 | 31527615 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 9.80e-06 | 7 | 230 | 3 | 35176221 | |
| Pubmed | KRT72 ILF2 IQGAP2 SYNPO ERBIN RTN1 LACTB SYNGAP1 AP2M1 PRPF19 HSPA5 ARHGAP21 SEC23A CACNA1A ACSL6 WASL FN1 YTHDC2 GRIN2B MAP7 CBR1 CIT TENM4 PEBP1 CDH2 | 1.05e-05 | 1431 | 230 | 25 | 37142655 | |
| Pubmed | PDE3B ZNF318 ANKLE2 ERBIN HSPA5 ARHGAP21 EHBP1 YTHDC2 LRBA VPS13B | 1.13e-05 | 263 | 230 | 10 | 34702444 | |
| Pubmed | 1.16e-05 | 209 | 230 | 9 | 36779422 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TMEM106C IFI30 PRPF19 HSPA5 ARHGAP21 COL12A1 COL15A1 TUT7 DERL2 RANBP6 RNF213 PRSS23 MAP7 NUP35 TGFB1 SLC30A7 TMX2 ATF6 CELSR1 IGF2R CDH2 CDH13 | 1.79e-05 | 1201 | 230 | 22 | 35696571 |
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 1.80e-05 | 82 | 230 | 6 | 31073041 | |
| Pubmed | ZNF280A CDS2 SYNPO NUP58 ERBIN LPIN1 SH3RF2 TMEM106C EHBP1 CACNA1E COL12A1 PRSS23 ATAD2 SPATA32 TGFB1 SLC7A1 ATF6 MTOR PEBP1 PRKCH DUSP10 POLQ DCP1A | 1.82e-05 | 1293 | 230 | 23 | 15342556 | |
| Pubmed | VWA8 ZNF318 CUL7 FBXL6 JAK1 GSE1 NFRKB XYLB KAT5 PHF12 RNF213 YTHDC2 MAP7 RAB11FIP1 NCKAP5L INTS13 TADA2B SMARCA2 MTR LRRC8B NUP188 | 1.89e-05 | 1116 | 230 | 21 | 31753913 | |
| Pubmed | 2.33e-05 | 9 | 230 | 3 | 16382099 | ||
| Pubmed | VWA8 SYNPO CUL7 BPIFA1 ERBIN AP2M1 LOXL4 ARHGAP21 ECPAS CBR1 SLC7A2 IGF2R SMARCA2 NUP188 MVK | 2.42e-05 | 634 | 230 | 15 | 34591612 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | HIVEP2 NUP58 GSE1 NFRKB NCOA2 KAT5 PHF12 NUP214 ASXL3 SMARCA2 CDH2 | 2.49e-05 | 351 | 230 | 11 | 38297188 |
| Pubmed | HIPK1 PLEKHH1 LPIN1 NCOA2 CACNA1A GARIN5B CACNA1E YTHDC2 ACOT1 | 2.74e-05 | 233 | 230 | 9 | 37704626 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ILF2 NCBP1 AP2M1 RBM19 EIF2B5 PRPF19 HSPA5 SEC23A YTHDC2 NUP214 ECPAS ADNP ATAD2 CBR1 NUP35 IPO9 IGF2R PABPN1 MTOR PEBP1 MTR CCAR1 LTV1 NUP188 | 2.86e-05 | 1425 | 230 | 24 | 30948266 |
| Pubmed | PDE3B RAPGEF6 LPIN1 PARP4 PSME4 GSE1 EIF2B5 DENND5A ARHGAP21 TUT7 YTHDC2 MORC2 PALS1 MTR CCAR1 | 3.22e-05 | 650 | 230 | 15 | 38777146 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | PARP4 AP2M1 PRPF19 ARHGAP21 SEC23A TUT7 YTHDC2 PRSS23 CBR1 CIT TGFB1 CELSR1 PABPN1 PEBP1 LTV1 CUX1 | 3.37e-05 | 732 | 230 | 16 | 34732716 |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.41e-05 | 135 | 230 | 7 | 28675934 | |
| Pubmed | SCFD2 ANKLE2 RTN1 TMEM106C SEC23A STXBP5 NUP35 SLC30A7 ATF6 SLC7A2 IGF2R LRBA VPS13B | 3.54e-05 | 504 | 230 | 13 | 34432599 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | PDE3B ILF2 NCBP1 PARP4 GSE1 ALDH16A1 HSPA5 PLXNB3 CFAP47 MXRA5 FN1 RNF213 ICE1 ECPAS KDM4D NUP188 | 3.59e-05 | 736 | 230 | 16 | 29676528 |
| Pubmed | CDS2 NCBP1 JAK1 TMEM106C EIF2B5 HSPA5 RANBP6 ECPAS SLC30A7 SLC7A1 IPO9 IGF2R PABPN1 MTOR NUP188 | 3.64e-05 | 657 | 230 | 15 | 36180527 | |
| Pubmed | 3.70e-05 | 93 | 230 | 6 | 7829101 | ||
| Pubmed | 3.83e-05 | 57 | 230 | 5 | 18022353 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ILF2 IREB2 NCBP1 PSME4 ALDH16A1 NFRKB PRPF19 HSPA5 SEC23A EIF4H RPP30 RANBP6 MAP7 ECPAS IPO9 SH2D4A MTOR INTS13 MTR LTV1 NUP188 LRBA OGA MVK | 3.98e-05 | 1455 | 230 | 24 | 22863883 |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 24966004 | ||
| Pubmed | DNA polymerase θ protects leukemia cells from metabolically induced DNA damage. | 4.35e-05 | 2 | 230 | 2 | 36580665 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 38807600 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 35534227 | ||
| Pubmed | A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. | 4.35e-05 | 2 | 230 | 2 | 9620694 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 22850629 | ||
| Pubmed | TGF-beta-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen. | 4.35e-05 | 2 | 230 | 2 | 16179614 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 28684763 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 23376566 | ||
| Pubmed | Cloning and sequencing of a novel human gene that encodes a putative target protein of Nesh-SH3. | 4.35e-05 | 2 | 230 | 2 | 11501947 | |
| Pubmed | The importance of cationic amino acid transporter expression in human skin. | 4.35e-05 | 2 | 230 | 2 | 12787129 | |
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 4.35e-05 | 2 | 230 | 2 | 33526815 | |
| Pubmed | The roles and action mechanisms of p160/SRC coactivators and the ANCCA coregulator in cancer. | 4.35e-05 | 2 | 230 | 2 | 20374707 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 36587526 | ||
| Pubmed | Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions? | 4.35e-05 | 2 | 230 | 2 | 22988872 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 9174363 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 20720212 | ||
| Pubmed | Genetic Analysis of LRRK1 and LRRK2 Variants in Essential Tremor Patients. | 4.35e-05 | 2 | 230 | 2 | 29812962 | |
| Pubmed | Dynamic and redundant regulation of LRRK2 and LRRK1 expression. | 4.35e-05 | 2 | 230 | 2 | 18045479 | |
| Pubmed | Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease. | 4.35e-05 | 2 | 230 | 2 | 20144646 | |
| Pubmed | Variants in the LRRK1 gene and susceptibility to Parkinson's disease in Norway. | 4.35e-05 | 2 | 230 | 2 | 17324517 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 20375166 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 20231426 | ||
| Pubmed | Fibronectin fibrils regulate TGF-β1-induced Epithelial-Mesenchymal Transition. | 4.35e-05 | 2 | 230 | 2 | 28109697 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 14507636 | ||
| Pubmed | The influence of the peptide NAP on Mac-1-deficient mice following closed head injury. | 4.35e-05 | 2 | 230 | 2 | 16042992 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 26586478 | ||
| Pubmed | Regulation of cationic amino acid transporter (CAT) gene expression. | 4.35e-05 | 2 | 230 | 2 | 8878860 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 12097557 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 24391143 | ||
| Pubmed | Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin. | 4.35e-05 | 2 | 230 | 2 | 18172665 | |
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 4.35e-05 | 2 | 230 | 2 | 24096970 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 10952971 | ||
| Pubmed | The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells. | 4.35e-05 | 2 | 230 | 2 | 27345520 | |
| GeneFamily | Nucleoporins | 1.30e-04 | 32 | 148 | 4 | 1051 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 6.55e-04 | 5 | 148 | 2 | 1182 | |
| GeneFamily | Collagens|Collagen proteoglycans | 6.55e-04 | 5 | 148 | 2 | 575 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 9.59e-04 | 24 | 148 | 3 | 485 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 9.77e-04 | 6 | 148 | 2 | 1181 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.22e-03 | 26 | 148 | 3 | 253 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | HIPK1 ZNF318 ANKLE2 PSME4 C2orf42 ZAN YTHDC2 NUP214 ECPAS MTR | 2.10e-06 | 167 | 227 | 10 | M361 |
| Coexpression | HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS | 4.79e-06 | 77 | 227 | 7 | M19128 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 9.99e-06 | 199 | 227 | 10 | M5970 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | RAPGEF6 HIVEP2 ABI3 ERBIN BTG2 NFRKB NCOA2 WASL ADNP NCKAP5L | 1.04e-05 | 200 | 227 | 10 | M9260 |
| Coexpression | GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP | 3.03e-05 | 181 | 227 | 9 | M6857 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 5.86e-05 | 197 | 227 | 9 | M7403 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 5.86e-05 | 197 | 227 | 9 | M4421 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_DN | 6.03e-05 | 78 | 227 | 6 | M9814 | |
| Coexpression | GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP | ILF2 VWA8 HLA-DOA RASSF2 HLA-DQA1 ZNF318 TMEM106C IFI30 FGD2 | 6.33e-05 | 199 | 227 | 9 | M7210 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 6.46e-05 | 155 | 227 | 8 | M8944 | |
| Coexpression | GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP | 6.58e-05 | 200 | 227 | 9 | M5668 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | HLA-DQA1 HIPK1 ZNF318 NUP58 ANKLE2 NIBAN3 PSME4 UROS EHBP1 YTHDC2 ECPAS DNAH1 CCAR1 DUSP10 | 7.34e-05 | 474 | 227 | 14 | M40991 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | RAPGEF6 IQGAP2 VWA8 WASL HIPK2 RANBP6 NUP214 ECPAS SEMA3D VPS13B CUX1 DCP1A | 2.09e-05 | 261 | 222 | 12 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#5 | HIVEP2 ITGB6 SERPING1 FGF12 CACNA1B FGD2 LAD1 LRRK1 MAP7 TATDN3 SEMA3D CELSR1 SAMD10 NDRG4 | 6.84e-05 | 391 | 222 | 14 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#1 | ITGB6 SERPING1 FGF12 CACNA1B FGD2 LAD1 MAP7 SEMA3D CELSR1 SAMD10 NDRG4 | 9.41e-05 | 259 | 222 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#5 | HIVEP2 ITGB6 IFI30 SERPING1 FGF12 CACNA1B FGD2 LAD1 LRRK1 RAB11FIP1 SEMA3D SAMD10 SMARCA2 NDRG4 | 1.02e-04 | 406 | 222 | 14 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 1.05e-04 | 24 | 222 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SYNPO RTN1 ITGB6 PLEKHH1 COL24A1 GSE1 SERPING1 FGF12 CACNA1B ABI3BP FGD2 LAD1 DERL2 RNF213 MAP7 RAB11FIP1 SLC7A2 SEMA3D CELSR1 SAMD10 LRRC8B CDH2 NDRG4 CDH13 | 1.06e-04 | 984 | 222 | 24 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_100 | 1.24e-04 | 25 | 222 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_200 | 1.28e-04 | 47 | 222 | 5 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k1_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | 1.45e-04 | 76 | 222 | 6 | GSM538248_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-3 | 1.45e-04 | 76 | 222 | 6 | GSM538249_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_100 | 1.45e-04 | 26 | 222 | 4 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2 | 1.67e-04 | 78 | 222 | 6 | GSM538266_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500 | 1.69e-04 | 148 | 222 | 8 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_500 | |
| CoexpressionAtlas | B cells, B.FrE.BM, CD19+ IgM+ AA4.1+ HSA+, Bone marrow, avg-3 | BHLHE41 ABI3 HLA-DQA1 LRRK2 ZNF318 NIBAN3 IFI30 CACNA1E FGD2 ATP13A2 TGFB1 DUSP10 CUX1 | 1.75e-04 | 376 | 222 | 13 | GSM399438_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1 | 1.80e-04 | 79 | 222 | 6 | GSM538265_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.Sp, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Spleen, avg-2 | 1.93e-04 | 80 | 222 | 6 | GSM605837_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#4 | HIVEP2 ITGB6 IFI30 SERPING1 FGF12 CACNA1B LAD1 LRRK1 MAP7 SEMA3D SMARCA2 NDRG4 | 2.19e-04 | 334 | 222 | 12 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K4 |
| CoexpressionAtlas | Myeloid Cells, DC.4+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 2.21e-04 | 82 | 222 | 6 | GSM538242_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | RTN1 ITGB6 PLEKHH1 SERPING1 FGF12 FGD2 LAD1 DERL2 MAP7 RAB11FIP1 CELSR1 SAMD10 LRRC8B CDH2 NDRG4 | 2.38e-04 | 495 | 222 | 15 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-2 | 2.68e-04 | 85 | 222 | 6 | GSM538258_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#3 | HIVEP2 ITGB6 IFI30 SERPING1 FGF12 CACNA1B LAD1 LRRK1 MAP7 SEMA3D NDRG4 | 3.18e-04 | 298 | 222 | 11 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | HIVEP2 ITGB6 IFI30 SERPING1 FGF12 CACNA1B LAD1 LRRK1 MAP7 SEMA3D NDRG4 | 3.87e-04 | 305 | 222 | 11 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K3 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 3.88e-04 | 91 | 222 | 6 | GSM777059_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_200 | 4.09e-04 | 60 | 222 | 5 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#4 | HIVEP2 ITGB6 IFI30 SERPING1 FGF12 CACNA1B LAD1 LRRK1 MAP7 SEMA3D NDRG4 | 4.09e-04 | 307 | 222 | 11 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K4 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | RIMS3 LRRK2 STYK1 CCDC168 CHRM2 PRR16 COL12A1 LRRK1 SMARCA2 CUX1 | 2.93e-08 | 177 | 229 | 10 | f902600c639087664316b3cf30cab243bc3d1c5c |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B PKD1L2 COL24A1 COL12A1 STAB2 ZAN GRIN2B DNAH1 TENM4 ASXL3 | 4.23e-08 | 184 | 229 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B PKD1L2 COL24A1 COL12A1 STAB2 ZAN GRIN2B DNAH1 TENM4 ASXL3 | 4.23e-08 | 184 | 229 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B PKD1L2 COL24A1 COL12A1 STAB2 ZAN GRIN2B DNAH1 TENM4 ASXL3 | 4.23e-08 | 184 | 229 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | FILIP1 PDE3B PRR16 COL24A1 GSE1 ABI3BP SEMA3D ASPA SMARCA2 OGA | 5.73e-08 | 190 | 229 | 10 | 62a3ec1ae0829602b0569cc051210551644f1d46 |
| ToppCell | facs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HLA-DQA1 PKD1L2 ITGAM IFI30 LILRB3 FGD2 LILRA6 RAB11FIP1 CCDC180 | 1.16e-07 | 155 | 229 | 9 | d0c1608f8f6b6f4174e51d610501c707cba5e015 |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | BHLHE41 ZNF318 IFI30 DENND5A ACOT1 LRRK1 RAB11FIP1 ZCCHC4 DCP1A | 2.18e-07 | 167 | 229 | 9 | 881f64db8dea3faa7588bf04d87c20924a4e5952 |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | IQGAP2 HLA-DOA HLA-DQA1 PKD1L2 IFI30 LILRB3 FLT3 FGD2 LILRA6 | 2.54e-07 | 170 | 229 | 9 | 138235227fc4c3d660c3a06e8e5167bf64f076b3 |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | ZNF280A RASSF2 HLA-DQA1 NIBAN3 COL24A1 FLT3 FGD2 LRRK1 LILRA4 | 2.67e-07 | 171 | 229 | 9 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 4.95e-07 | 184 | 229 | 9 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.18e-07 | 185 | 229 | 9 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | HLA-DOA RASSF2 HLA-DQA1 ITGAM IFI30 LILRB5 LILRB3 FGD2 LILRA6 | 5.92e-07 | 188 | 229 | 9 | 239bec13476dd43bebc2c6eba8d1fe35f2744673 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-07 | 190 | 229 | 9 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | HLA-DOA HLA-DQA1 RTN1 LACTB IFI30 FLT3 ACSF2 RAB11FIP1 TENM4 | 6.76e-07 | 191 | 229 | 9 | 6cda82a994f4b205cf54590c979d7c9f3be2b4c8 |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | HLA-DOA HLA-DQA1 RTN1 LACTB IFI30 FLT3 ACSF2 RAB11FIP1 TENM4 | 6.76e-07 | 191 | 229 | 9 | 4257f02856f3510981e9f84d465d91448d6126e2 |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 6.76e-07 | 191 | 229 | 9 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-07 | 193 | 229 | 9 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory|lymph-node_spleen / Manually curated celltypes from each tissue | BHLHE41 HLA-DOA HLA-DQA1 LRRK2 SYNPO IFI30 FGD2 LRRK1 LILRA4 | 7.70e-07 | 194 | 229 | 9 | b57ae94a092b58623a244a258b4659a3864542c7 |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 7.70e-07 | 194 | 229 | 9 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Memory_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | BHLHE41 HLA-DOA HLA-DQA1 NIBAN3 IFI30 FGD2 LRRK1 RAB11FIP1 LILRA4 | 8.04e-07 | 195 | 229 | 9 | 8b307079cee67fc1df55277d0cab21ea4b97e552 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | IQGAP2 RIMS3 NIBAN3 COL24A1 FLT3 RAB11FIP1 ATP13A2 IGF2R LILRA4 | 8.04e-07 | 195 | 229 | 9 | 06051de72b5c1e0d483a28b14dabd247dfca0ed9 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | IQGAP2 RIMS3 NIBAN3 COL24A1 FLT3 RAB11FIP1 ATP13A2 IGF2R LILRA4 | 8.04e-07 | 195 | 229 | 9 | 3aa44633c72658545aa2b35bf9d532c62f36a451 |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 8.39e-07 | 196 | 229 | 9 | 1868ad537b7f04cdad0a0c8282aadbc4f257a722 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.75e-07 | 197 | 229 | 9 | 555ea43eccc3eb22be230c27e13d8b3b64c2a61f | |
| ToppCell | Healthy-cDC|World / disease group, cell group and cell class | HLA-DOA HLA-DQA1 RTN1 LACTB IFI30 FLT3 ACSF2 RAB11FIP1 TENM4 | 9.13e-07 | 198 | 229 | 9 | 8976f8d26cb7ff79f74def138c4bbbb0bc2eaf00 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 148 | 229 | 8 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 1.24e-06 | 152 | 229 | 8 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.51e-06 | 156 | 229 | 8 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 160 | 229 | 8 | 822adcf5f9208f305cafffd8ed97f3a061e82b03 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.83e-06 | 160 | 229 | 8 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.83e-06 | 160 | 229 | 8 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-06 | 162 | 229 | 8 | 4c6e0cadd0ff50b0f50e0cfdc9027210e72674b9 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.01e-06 | 162 | 229 | 8 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-06 | 162 | 229 | 8 | 76e289ad9fd3694f77fd0d19e74c1cb8e87b8094 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-06 | 164 | 229 | 8 | 5ca7b69684a8bb12dd0b45e7ad94e30d16ed01ce | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 164 | 229 | 8 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-06 | 166 | 229 | 8 | 0590e404f45afce90e20f93f90a3def83949c66b | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 167 | 229 | 8 | c2952d8ba763374c5678b92825c8956fc3e3ecd2 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-06 | 169 | 229 | 8 | 3e40ae0b23a962e0f15908872dec63f51c5b8b83 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.00e-06 | 171 | 229 | 8 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.00e-06 | 171 | 229 | 8 | 38a05b5ec8ef8f09a2399994c6b4b9a707918ec1 | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 3.00e-06 | 171 | 229 | 8 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | COVID-19_Convalescent-cDC|COVID-19_Convalescent / Disease condition and Cell class | 3.00e-06 | 171 | 229 | 8 | 9ccaa9f1629818b0f63a5d930ee78c01e04cd98d | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.00e-06 | 171 | 229 | 8 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 171 | 229 | 8 | 159ce6d5513008532dd7785b915b3fe7440cc4b2 | |
| ToppCell | COVID-19_Convalescent-cDC-|COVID-19_Convalescent / Disease condition and Cell class | 3.00e-06 | 171 | 229 | 8 | fb5fae8b3adafcbb7c5618d887966b418355ed4d | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroid_progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-06 | 172 | 229 | 8 | 910ec7794ea4000db4ef1e2c34e08dbc0243df2c | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-06 | 174 | 229 | 8 | 28ec25767bbd4fd898738f9f4d2b585dc91b5adf | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | BHLHE41 HLA-DOA HLA-DQA1 NIBAN3 COL24A1 IFI30 COL12A1 GRIN2B | 3.57e-06 | 175 | 229 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-06 | 177 | 229 | 8 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 3.88e-06 | 177 | 229 | 8 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.57e-06 | 181 | 229 | 8 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-06 | 183 | 229 | 8 | a97f052950429245c3231464271e1ba539863bba | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.96e-06 | 183 | 229 | 8 | b12b89debc9dd6396188bc8fe44f54c01c560966 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.96e-06 | 183 | 229 | 8 | 19cc0009f5332b6e4d4274df123eebbfc80b669a | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 185 | 229 | 8 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-06 | 185 | 229 | 8 | e592c27f711d13bfc6546893acaab4c8600b0be1 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 185 | 229 | 8 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-06 | 186 | 229 | 8 | bec4767eaca28e41da373274704895eba75063e2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.59e-06 | 186 | 229 | 8 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-06 | 186 | 229 | 8 | 69b107ad88b07e9aeef09d4e4dac99b0cb6b467e | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-06 | 186 | 229 | 8 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 5.81e-06 | 187 | 229 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.83e-06 | 133 | 229 | 7 | 29b0c2c682c6b97823e7d8d8ba1f5114044b30ba | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-06 | 189 | 229 | 8 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-06 | 189 | 229 | 8 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.29e-06 | 189 | 229 | 8 | 1d660bceee449aebf12fc9af4c74af246837b27a | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.29e-06 | 189 | 229 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-06 | 135 | 229 | 7 | 0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.43e-06 | 135 | 229 | 7 | 7743a01dc9c4542e910e7c0fe046004692a680bf | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.53e-06 | 190 | 229 | 8 | d4aefae2d3164db6a9e953c54af0151501e9d1da | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 6.53e-06 | 190 | 229 | 8 | e9507bb0c8ff3d071402731a9b8cfe1bba93fab0 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.53e-06 | 190 | 229 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 6.53e-06 | 190 | 229 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-06 | 191 | 229 | 8 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 6.79e-06 | 191 | 229 | 8 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.79e-06 | 191 | 229 | 8 | de7c88bb46f794291025ef121a89fcd94dea4ffe | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.79e-06 | 191 | 229 | 8 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.79e-06 | 191 | 229 | 8 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.79e-06 | 191 | 229 | 8 | 4c4f50a502e3f6768a89df686fa2830b83b8b33f | |
| ToppCell | IPF-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 6.79e-06 | 191 | 229 | 8 | f2ddc0962007d7a4e78fbd916ebb62fc557d480a | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.05e-06 | 192 | 229 | 8 | 5417f024fcc89eaeab33f4a2c6421d1cfabd681b | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.05e-06 | 192 | 229 | 8 | 22f335e6e75a694cdccafe189b5ee7815ef28c03 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.05e-06 | 192 | 229 | 8 | 34505a13b8a47c9286c560122fa7861b9c331a08 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.05e-06 | 192 | 229 | 8 | 57c1410ebf90c230993e065eb78385daa3360960 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.05e-06 | 192 | 229 | 8 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 193 | 229 | 8 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 193 | 229 | 8 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.33e-06 | 193 | 229 | 8 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 193 | 229 | 8 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 193 | 229 | 8 | 95e64b9580d30c28702639a043a8b72ce1cadeb6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 193 | 229 | 8 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 193 | 229 | 8 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 193 | 229 | 8 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | Control-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 7.43e-06 | 138 | 229 | 7 | b7920c9a28d28220e7e4b30cd91ba13d0548eb76 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 7.61e-06 | 194 | 229 | 8 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.61e-06 | 194 | 229 | 8 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-06 | 194 | 229 | 8 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | CF-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 7.61e-06 | 194 | 229 | 8 | 3feb8a0ba3368673c53e9cbd4980e73d18697718 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.61e-06 | 194 | 229 | 8 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| Drug | KN-62 | ITGAM CHRM2 SYNGAP1 JAK1 XYLB PKN3 CACNA1A CACNA1B CACNA1E FN1 NUP214 GRIN2B SIRT6 PRKCH LRBA | 1.03e-08 | 230 | 225 | 15 | CID000003838 |
| Drug | GF109203X | KCNH7 CHRM2 NMB PKN3 CACNA1A CACNA1B CACNA1E KAT5 NUP214 GRIN2B SIRT6 SLC7A1 SLC7A2 MTOR PRKCH LRBA | 3.19e-07 | 341 | 225 | 16 | CID000002396 |
| Drug | BAPTA | CHRM2 RBM19 HSPA5 PKN3 CACNA1A CACNA1B CACNA1E FN1 PHF12 NUP214 GRIN2B SIRT6 MKNK1 PRKCH LRBA | 8.91e-07 | 324 | 225 | 15 | CID000104751 |
| Drug | LY320135 | 2.62e-06 | 23 | 225 | 5 | CID005311257 | |
| Drug | AC 110 | 3.78e-06 | 4 | 225 | 3 | CID000022860 | |
| Drug | aristolactam | 3.78e-06 | 4 | 225 | 3 | CID000096710 | |
| Drug | 9-beta-D-arabinofuranosylguanine | PDE3B IQGAP2 TBL1Y IREB2 NCBP1 SYNPO CHRM2 DENND5A PKN3 CACNA1B CACNA1E WASL KAT5 EIF4H RPP30 ODC1 SIRT6 CIT GFM2 MTOR PRKCH LRBA POLQ | 1.14e-05 | 843 | 225 | 23 | CID000000765 |
| Drug | Asbestos, Serpentine | BHLHE41 HIVEP2 RIMS3 STYK1 RRM2 BPIFA1 PTPRN DENND5A HSPA5 FN1 TGFB1 ATF6 SLC7A2 MTOR DUSP10 CDH13 | 1.17e-05 | 451 | 225 | 16 | ctd:D017632 |
| Drug | prostaglandin F2 | PDE3B CHRM2 RBM19 IFI30 PKN3 KAT5 ODC1 SIRT6 CBR1 TGFB1 MTOR TSPAN10 PRKCH | 1.22e-05 | 306 | 225 | 13 | CID000000160 |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | NUP58 LPIN1 HSPA5 NCOA2 DERL2 RAB11FIP1 ECPAS ATP13A2 ZNF839 NDRG4 | 1.56e-05 | 184 | 225 | 10 | 1051_UP |
| Drug | barium | CHRM2 SERPING1 CACNA1A CACNA1B CACNA1E PHF12 SIRT6 MTR PRKCH | 1.71e-05 | 148 | 225 | 9 | CID000104810 |
| Drug | 3,4-dihydroquinazoline | 1.86e-05 | 6 | 225 | 3 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 1.86e-05 | 6 | 225 | 3 | CID000133976 | |
| Drug | Bay K 8644 | 1.90e-05 | 150 | 225 | 9 | CID000002303 | |
| Drug | foscarnet | RRM2 COL24A1 PSME4 CACNA1A CACNA1B CACNA1E COL12A1 GRIN2B ATAD2 POLQ | 2.05e-05 | 190 | 225 | 10 | CID000003414 |
| Drug | DPCPX | 2.17e-05 | 117 | 225 | 8 | CID000001329 | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A | PDE3B TBL1Y STYK1 FGF12 MTHFSD SLC7A2 SH2D4A LRRC8B DUSP10 VPS13B | 2.93e-05 | 198 | 225 | 10 | 3248_UP |
| Drug | calmidazolium chloride | 3.17e-05 | 160 | 225 | 9 | CID000002531 | |
| Drug | APMPA | 3.24e-05 | 7 | 225 | 3 | CID000512300 | |
| Drug | 8-cyclopentyltheophylline | 3.47e-05 | 38 | 225 | 5 | CID000001917 | |
| Drug | gentiopicroside | 5.14e-05 | 8 | 225 | 3 | CID000088708 | |
| Drug | AC1L1JM9 | PDE3B ITGAM ERBIN XYLB PKN3 KAT5 FN1 SOCS3 SIRT6 TGFB1 MTOR PRKCH | 5.38e-05 | 304 | 225 | 12 | CID000005103 |
| Drug | 4-AP | CHRM2 RBM19 PKN3 CACNA1A CACNA1B CACNA1E PHF12 GRIN2B SIRT6 MTR PRKCH | 5.54e-05 | 258 | 225 | 11 | CID000001727 |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.58e-05 | 172 | 225 | 9 | 6439_DN | |
| Drug | chrysene | ILF2 HLA-DOA RRM2 LPIN1 PKN3 EHBP1 WASL RNF169 ABI3BP FAM13C LCORL ACOT1 LRRK1 PRSS23 RAB11FIP1 TENM4 PEBP1 LTV1 LRRC8B EML1 OGA CDH13 | 5.67e-05 | 871 | 225 | 22 | ctd:C031180 |
| Drug | AC1L1BDQ | 5.84e-05 | 173 | 225 | 9 | CID000001394 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.38e-05 | 175 | 225 | 9 | 6736_DN | |
| Disease | Epileptic encephalopathy | 2.39e-09 | 30 | 225 | 7 | C0543888 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 4.38e-07 | 3 | 225 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 1.74e-06 | 4 | 225 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.50e-05 | 7 | 225 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Liver carcinoma | IQGAP2 RRM2 BTG2 HSPA5 LILRB5 STAB2 COL15A1 SOCS3 CBR1 TGFB1 IGF2R MTOR CDH13 MVK | 3.90e-05 | 507 | 225 | 14 | C2239176 |
| Disease | cancer (implicated_via_orthology) | 4.37e-05 | 268 | 225 | 10 | DOID:162 (implicated_via_orthology) | |
| Disease | Global developmental delay | 7.53e-05 | 133 | 225 | 7 | C0557874 | |
| Disease | outer ear morphology trait | 9.15e-05 | 12 | 225 | 3 | EFO_0007664 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 1.18e-04 | 13 | 225 | 3 | DOID:11758 (biomarker_via_orthology) | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 1.50e-04 | 14 | 225 | 3 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | red wine liking measurement | 1.73e-04 | 3 | 225 | 2 | EFO_0006947 | |
| Disease | cathepsin L1 measurement | 2.28e-04 | 16 | 225 | 3 | EFO_0010619 | |
| Disease | epilepsy (implicated_via_orthology) | 2.66e-04 | 163 | 225 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | bacterial pathogen genotype measurement, pulmonary tuberculosis | 2.75e-04 | 17 | 225 | 3 | EFO_0010271, EFO_1000049 | |
| Disease | heart rate | 3.52e-04 | 225 | 225 | 8 | EFO_0004326 | |
| Disease | Leukemia, Myelocytic, Acute | 3.81e-04 | 173 | 225 | 7 | C0023467 | |
| Disease | Epilepsy, Cryptogenic | 4.18e-04 | 82 | 225 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 4.18e-04 | 82 | 225 | 5 | C0751111 | |
| Disease | Aura | 4.18e-04 | 82 | 225 | 5 | C0236018 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 5.33e-04 | 49 | 225 | 4 | EFO_0006954, EFO_1001069 | |
| Disease | eosinophilic esophagitis (is_implicated_in) | 5.70e-04 | 5 | 225 | 2 | DOID:13922 (is_implicated_in) | |
| Disease | seasonality measurement, vitamin D measurement | 5.70e-04 | 5 | 225 | 2 | EFO_0004631, EFO_0006876 | |
| Disease | Intellectual Disability | HIVEP2 SYNGAP1 AP2M1 MN1 CACNA1B CACNA1E GRIN2B ODC1 TMX2 MTOR CDH2 | 6.90e-04 | 447 | 225 | 11 | C3714756 |
| Disease | Neurodevelopmental Disorders | 7.43e-04 | 93 | 225 | 5 | C1535926 | |
| Disease | Ureteral obstruction | 7.87e-04 | 24 | 225 | 3 | C0041956 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 8.28e-04 | 55 | 225 | 4 | DOID:9952 (is_implicated_in) | |
| Disease | mitochondrial myopathy (implicated_via_orthology) | 8.51e-04 | 6 | 225 | 2 | DOID:699 (implicated_via_orthology) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 8.51e-04 | 6 | 225 | 2 | EFO_0802705 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 8.51e-04 | 6 | 225 | 2 | EFO_0801767 | |
| Disease | myelofibrosis (is_marker_for) | 8.51e-04 | 6 | 225 | 2 | DOID:4971 (is_marker_for) | |
| Disease | Abnormal corpus callosum morphology | 8.51e-04 | 6 | 225 | 2 | C1842581 | |
| Disease | Parkinson disease | HLA-DQA1 LRRK2 LACTB CACNA1B COL12A1 LCORL MMRN1 ASXL3 CDH13 | 8.52e-04 | 321 | 225 | 9 | MONDO_0005180 |
| Disease | L lactate dehydrogenase measurement | 9.99e-04 | 26 | 225 | 3 | EFO_0004808 | |
| Disease | Developmental regression | 1.19e-03 | 7 | 225 | 2 | C1836830 | |
| Disease | acute myocardial infarction (is_marker_for) | 1.19e-03 | 7 | 225 | 2 | DOID:9408 (is_marker_for) | |
| Disease | response to interferon-beta | 1.19e-03 | 7 | 225 | 2 | GO_0035456 | |
| Disease | Schizophrenia | RAPGEF6 RIMS3 ITGAM CHRM2 SYNGAP1 SLC23A3 CACNA1B ACSL6 GRIN2B ADNP TGFB1 SEMA3D TENM4 MTOR SMARCA2 MTR | 1.30e-03 | 883 | 225 | 16 | C0036341 |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.34e-03 | 157 | 225 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | tuberculosis | 1.40e-03 | 216 | 225 | 7 | MONDO_0018076 | |
| Disease | fish consumption measurement | 1.46e-03 | 64 | 225 | 4 | EFO_0010139 | |
| Disease | cognitive function measurement | KCNH7 IREB2 BPIFA1 JAK1 PRR16 RNF214 SERPING1 LOXL4 FGF12 ARHGAP21 NCOA2 CACNA1E LCORL YTHDC2 GRIN2B PRSS23 IPO9 TENM4 DDX53 OGA CDH2 CDH13 | 1.51e-03 | 1434 | 225 | 22 | EFO_0008354 |
| Disease | Epilepsy | 1.51e-03 | 109 | 225 | 5 | C0014544 | |
| Disease | insulinoma (is_marker_for) | 1.57e-03 | 8 | 225 | 2 | DOID:3892 (is_marker_for) | |
| Disease | LEUKEMIA, ACUTE LYMPHOBLASTIC | 1.57e-03 | 8 | 225 | 2 | 613065 | |
| Disease | Acute lymphoid leukemia | 1.57e-03 | 8 | 225 | 2 | cv:C0023449 | |
| Disease | hearing loss | 1.73e-03 | 67 | 225 | 4 | EFO_0004238 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.83e-03 | 68 | 225 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | Endomyocardial Fibrosis | 2.01e-03 | 9 | 225 | 2 | C0553980 | |
| Disease | prostate cancer (is_implicated_in) | 2.07e-03 | 117 | 225 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | Myocardial Ischemia | 2.38e-03 | 176 | 225 | 6 | C0151744 | |
| Disease | serum IgG glycosylation measurement | HIVEP2 ABI3 HLA-DOA IREB2 ALDH1L2 CACNA1E STAB2 SOCS3 TEK ATF6 CDH13 | 2.40e-03 | 523 | 225 | 11 | EFO_0005193 |
| Disease | Focal glomerulosclerosis | 2.59e-03 | 36 | 225 | 3 | C0017668 | |
| Disease | electrocardiography | HLA-DOA HLA-DQA1 CDIN1 SLC25A26 GMEB2 RBM19 NCOA2 YTHDC2 CDH2 NDRG4 CDH13 | 2.65e-03 | 530 | 225 | 11 | EFO_0004327 |
| Disease | platelet crit | SCFD2 BHLHE41 IQGAP2 LRRK2 ZNF318 JAK1 GSE1 MN1 PKN3 NCOA2 WASL FLT3 KAT5 SOCS3 TADA2B CUX1 | 2.76e-03 | 952 | 225 | 16 | EFO_0007985 |
| Disease | heel bone mineral density, urate measurement | 2.81e-03 | 182 | 225 | 6 | EFO_0004531, EFO_0009270 | |
| Disease | lymphoid leukemia | 3.03e-03 | 38 | 225 | 3 | EFO_0004289 | |
| Disease | Nephrosclerosis | 3.04e-03 | 11 | 225 | 2 | C0027719 | |
| Disease | Macrocephaly | 3.04e-03 | 11 | 225 | 2 | C0221355 | |
| Disease | Aortic Valve Insufficiency | 3.04e-03 | 11 | 225 | 2 | C0003504 | |
| Disease | factor VIII deficiency (is_implicated_in) | 3.04e-03 | 11 | 225 | 2 | DOID:12134 (is_implicated_in) | |
| Disease | Ashkenazi Jewish disorders | 3.04e-03 | 11 | 225 | 2 | cv:CN118946 | |
| Disease | glycerophosphorylcholine measurement | 3.04e-03 | 11 | 225 | 2 | EFO_0020018 | |
| Disease | factor VIII measurement | 3.51e-03 | 40 | 225 | 3 | EFO_0004630 | |
| Disease | Centriacinar Emphysema | 3.63e-03 | 12 | 225 | 2 | C0221227 | |
| Disease | Panacinar Emphysema | 3.63e-03 | 12 | 225 | 2 | C0264393 | |
| Disease | Focal Emphysema | 3.63e-03 | 12 | 225 | 2 | C2350878 | |
| Disease | Papilloma | 3.63e-03 | 12 | 225 | 2 | C0030354 | |
| Disease | Papillomatosis | 3.63e-03 | 12 | 225 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 3.63e-03 | 12 | 225 | 2 | C0205874 | |
| Disease | Bipolar Disorder | BHLHE41 ITGAM CHRM2 HSPA5 CACNA1A CACNA1B GRIN2B TGFB1 TENM4 MTR | 3.82e-03 | 477 | 225 | 10 | C0005586 |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.94e-03 | 84 | 225 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | high grade glioma (is_marker_for) | 4.03e-03 | 42 | 225 | 3 | DOID:3070 (is_marker_for) | |
| Disease | aspartate aminotransferase measurement | RAPGEF6 IQGAP2 HLA-DQA1 LPIN1 CFAP299 LOXL4 LILRB5 RNF213 NUP214 TGFB1 TMX2 IPO9 MTOR LRBA MVK | 4.17e-03 | 904 | 225 | 15 | EFO_0004736 |
| Disease | hematologic cancer (implicated_via_orthology) | 4.27e-03 | 13 | 225 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | aplastic anemia (is_implicated_in) | 4.27e-03 | 13 | 225 | 2 | DOID:12449 (is_implicated_in) | |
| Disease | colon carcinoma (is_marker_for) | 4.27e-03 | 13 | 225 | 2 | DOID:1520 (is_marker_for) | |
| Disease | R-warfarin measurement | 4.38e-03 | 265 | 225 | 7 | EFO_0803324 | |
| Disease | cataract | 4.61e-03 | 141 | 225 | 5 | MONDO_0005129 | |
| Disease | reaction time measurement | KCNH7 IQGAP2 LRRK2 STYK1 CHRM2 COL24A1 BTG2 FAM13C GRIN2B CCAR1 CDH2 CDH13 | 4.87e-03 | 658 | 225 | 12 | EFO_0008393 |
| Disease | ureteral obstruction (biomarker_via_orthology) | 4.90e-03 | 45 | 225 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 4.96e-03 | 14 | 225 | 2 | C1858991 | |
| Disease | Diabetic Neuralgia | 4.96e-03 | 14 | 225 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 4.96e-03 | 14 | 225 | 2 | C0011882 | |
| Disease | gamma-glutamylglutamate measurement | 4.96e-03 | 14 | 225 | 2 | EFO_0021137 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 4.96e-03 | 14 | 225 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 4.96e-03 | 14 | 225 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 4.96e-03 | 14 | 225 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 4.96e-03 | 14 | 225 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 4.96e-03 | 14 | 225 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 4.96e-03 | 14 | 225 | 2 | C0271680 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 4.96e-03 | 14 | 225 | 2 | C0393835 | |
| Disease | precuneus cortex volume measurement | 4.96e-03 | 14 | 225 | 2 | EFO_0010326 | |
| Disease | Asbestosis | 4.96e-03 | 14 | 225 | 2 | C0003949 | |
| Disease | Pulmonary Fibrosis - from Asbestos Exposure | 4.96e-03 | 14 | 225 | 2 | C2930617 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 5.49e-03 | 147 | 225 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | obesity (biomarker_via_orthology) | 5.49e-03 | 147 | 225 | 5 | DOID:9970 (biomarker_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.65e-03 | 148 | 225 | 5 | C0279702 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 5.69e-03 | 15 | 225 | 2 | EFO_0009935 | |
| Disease | posterior thigh muscle volume | 5.69e-03 | 15 | 225 | 2 | EFO_0020931 | |
| Disease | resting heart rate | 5.81e-03 | 149 | 225 | 5 | EFO_0004351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPVVSNILNRVTPGS | 56 | P59817 | |
| TLPPVGVNRNRIKVT | 271 | Q86TX2 | |
| PTGPLVQRITKNILV | 176 | Q9NWW7 | |
| RPLKLVSGIPSLQVV | 201 | O00555 | |
| RLSIPKPNLNSTGVN | 306 | Q9H2P0 | |
| GLKPLVLVTFQSPVN | 121 | Q6ZRH7 | |
| QARISVGTKVKLPNP | 566 | Q7L0X2 | |
| VTRVQPEGPASKLLQ | 1356 | Q96RT1 | |
| GVTALSQDPQRILKP | 126 | Q86XL3 | |
| RPLKLVSGIPSLQIV | 196 | Q15878 | |
| PKGTTPRTRKILEQQ | 216 | Q8N9M1 | |
| ASLVPILASQPGIRK | 231 | Q8IZ83 | |
| TPQLLTQQVPLSKGT | 176 | Q9C0J9 | |
| GNRLLLPTPTVKQES | 1001 | Q8IX12 | |
| LSQGSVSEILARPKP | 581 | P39880 | |
| AGNTLVLKPAQVTPL | 611 | Q3SY69 | |
| TIQSKRQTPSPRLAL | 831 | Q14687 | |
| IRGPNPSKLIQQFLT | 401 | O95674 | |
| TKNRPLVRGQISPLL | 221 | Q12887 | |
| VSPSLVQGRIVKPNN | 231 | P08172 | |
| QPGALKSQRLPDLTT | 201 | Q96CM8 | |
| SPGQALSTVVKPLLQ | 696 | Q6PL18 | |
| ISLQPAPTKGQTVLL | 221 | P18850 | |
| LASSQPPEQRKGILK | 2916 | Q9NYQ6 | |
| STGINRNSIPLQLPV | 306 | Q8N531 | |
| QKRSIVVSPILIPEN | 136 | P55290 | |
| PESFTQLSRVGKPLI | 1236 | Q9P1Z9 | |
| VRNPQKAIPIGIVTS | 281 | P52569 | |
| LKSLLEGSQRPQAVP | 296 | Q96LY2 | |
| KTTPRQRSPLLNQPV | 346 | Q9NPI6 | |
| SNTVQLPLQKRLVPT | 51 | Q8N5N4 | |
| VLRPLKLVSGIPSLQ | 196 | Q00975 | |
| LPAGAVRTPLSQVNK | 2006 | O14578 | |
| VFSKSPVTLGQPNIL | 116 | P01909 | |
| NRLPLPLQTTSVGKT | 1776 | Q9C0F0 | |
| IGSGSLLQKLPPRLQ | 56 | A8MX76 | |
| RLLRSIKPIQPASQV | 101 | P0C854 | |
| PQLTSVPLGKVVSTL | 391 | Q9UKD1 | |
| PRKQTTSKILVRNIP | 826 | Q9Y4C8 | |
| NLGAQGTTLKPLTVP | 91 | P50749 | |
| KLSDPGIPITVLSRQ | 736 | P23458 | |
| INLNSIVPSVSGPKR | 436 | P48200 | |
| PTPQALATGIRKALQ | 246 | P10746 | |
| NRTQGIIPLAPISKS | 36 | Q9NVM9 | |
| PQEPTGSQLLRSKKL | 81 | Q86XR2 | |
| GQVISKTQPSSQRPL | 431 | Q9UPP5 | |
| TLATVQRLPPGQKVI | 111 | Q9P2A4 | |
| KFIIPGSPAIISIRQ | 886 | Q9Y5I1 | |
| PLLQVTSPVLQRLQG | 71 | Q16849 | |
| LQLKPRTVATPLNQV | 211 | Q15056 | |
| TTGIPVVKPRQLIAT | 2051 | Q14667 | |
| TVASRLPPVTLQVKI | 331 | O00515 | |
| PSRPQSLGTTKLRLV | 21 | Q96JB6 | |
| DPLQLLVSGVSRKPS | 211 | P59901 | |
| SRKPSLLTLQGPVVT | 221 | P59901 | |
| TGNPRTIIVPPLKTQ | 961 | Q9H2X6 | |
| IRISSKTGIPLNVLP | 376 | Q96GA3 | |
| INLPIGSKPSRLDVT | 696 | Q14244 | |
| QAGKLPTRITVPLSV | 1176 | Q6P4R8 | |
| KLQPGSLPQVLAQAT | 381 | Q09161 | |
| QKLQLTTGSLPQIPL | 106 | Q9HCH0 | |
| PPRQGKSTLLEILQT | 646 | Q38SD2 | |
| GTRTIIVPPLKTQLG | 981 | Q86Z02 | |
| ILQLLQKQTTVVPPA | 1056 | Q9NS40 | |
| PNKIQSLQILPTTRV | 46 | Q13201 | |
| NKVTLTNQLPPSTGR | 1016 | Q5HYC2 | |
| KSVGQSPLRSPLKRQ | 1296 | Q2LD37 | |
| SNPTVQLKIPQLRVS | 406 | Q8N3X6 | |
| ETINNKVPPRGIIVS | 506 | P83111 | |
| ASGKTLPIPVQITLR | 101 | Q92993 | |
| DLNNGVTPRILTPKL | 461 | Q9Y6W6 | |
| KPRSVLTSQVVVGPN | 426 | Q13144 | |
| PPVLLKLSSTQEGVR | 41 | Q5VYK3 | |
| SRPKIQLPVETLLVQ | 71 | Q5VYK3 | |
| VRVAIKSQPPGISSQ | 906 | Q9ULL4 | |
| PQSLILKLRPGGAQT | 106 | P18564 | |
| KPSVILQRSLGNAPN | 546 | Q13370 | |
| ELGKVLTPTQVKNRP | 36 | P30086 | |
| DPNLVPSISNKRIVG | 76 | P10606 | |
| QLPQVPGRVLFSLVK | 241 | Q14999 | |
| QTGLPLLSSPVPQRK | 811 | Q32MH5 | |
| PKTAGTLRQPTLEQA | 1276 | Q5T7B8 | |
| PTVLKENGIPFNRIT | 251 | Q6B0I6 | |
| PQILKVIATLLRNSP | 816 | P50851 | |
| TGEQPPQLSLATRVK | 581 | Q14693 | |
| APLKILNIGNVSTPL | 2286 | Q5S007 | |
| QNPGVKSLIKTPERL | 406 | P35658 | |
| SRKPSLLIPQGSVVA | 221 | O75023 | |
| VSRKPSLLTLQGPVL | 221 | Q6PI73 | |
| VSRKPSLLTLQGPVL | 221 | O75022 | |
| LAQKIEVRIPTPLNT | 316 | Q96CW1 | |
| VTLRESGPALVKPTQ | 21 | P01814 | |
| NHTVLSPRKGVPLQL | 166 | Q6ZUF6 | |
| KQLLGLQPISTVSPL | 1701 | Q9UKK3 | |
| RIPQVVTDLLPSLQK | 551 | Q6P9F7 | |
| VTSPSGQLIPVKNLS | 1141 | Q7Z442 | |
| LVKTASRPAPLVQQL | 681 | Q9Y6X9 | |
| GTLTFVLIPSQQIKP | 326 | Q8N3R9 | |
| LATLKPQAGLIVPQA | 131 | Q9UMS4 | |
| QIKVIPKRTNRPGIS | 241 | Q86U42 | |
| QTPQTTLPQLFLKVG | 251 | P36888 | |
| PTLIGTLGNPVKIRS | 3191 | Q9P2D7 | |
| NLLKPQTTPVIQALR | 726 | Q9NQ11 | |
| LEVPVSGLRSSNKPV | 126 | Q711Q0 | |
| LNILKGNIQLTRGPP | 1766 | Q9Y2F5 | |
| PTVPLAAKVNQRALT | 1086 | A4D2P6 | |
| IVPQALSGIIKRQPV | 941 | Q9Y2K7 | |
| NRLESVPQALTGLPK | 401 | Q9Y4C1 | |
| VTIPLGIKLQVNTPL | 131 | Q9NP55 | |
| TVLPKSRVELGQPNI | 116 | P06340 | |
| IAQLLVGPTAVVNPK | 791 | Q96AV8 | |
| ILTTQAPKSGPRNLQ | 1746 | Q99715 | |
| RGPLKKSNAPLVNVT | 51 | P13284 | |
| VSVPPTRQSLRKLKQ | 16 | Q9Y2V0 | |
| TATSVNIPDLLPGRK | 771 | P02751 | |
| RLPSGLDSVLQKTVP | 396 | O75417 | |
| ATVKILITTVPPNLR | 171 | Q12905 | |
| KPQLISPQGERLSQV | 491 | Q9BSJ5 | |
| PSVIRRLVTISPNNK | 1086 | Q6IQ26 | |
| LPLIKPQGRVVNVSS | 126 | P16152 | |
| SPVLGRKPNASQSLL | 436 | Q8NDI1 | |
| FQPTLLTLPRIKVTT | 391 | P05155 | |
| EKATAGQPRVTLLPT | 116 | Q7Z601 | |
| QTPSDFLKQIIGRPV | 6 | P62312 | |
| TILVPSNSGTLLPLK | 726 | Q6UXX5 | |
| PSNTLLREGPVLKIS | 316 | Q7Z6J4 | |
| TVVRNTKPPLSQLLI | 676 | Q96P70 | |
| NPISQGRSLPVKITV | 221 | Q14CZ8 | |
| SIIRVGIVKPTPIQS | 236 | Q86TM3 | |
| LPLRTTVNNGTVLPK | 91 | O00423 | |
| QVKGLPSINTSLLTP | 5066 | Q8NDH2 | |
| NQPGGIRILKTPSIL | 191 | Q9GZP9 | |
| LIPRNTVVPTKKSQI | 436 | P11021 | |
| APEIKIRLGSVQQPS | 1026 | D6RIA3 | |
| GSTQLLNEPKLSRPT | 746 | P39059 | |
| PLDTIKTRLQSPQGF | 26 | Q70HW3 | |
| SSGILKRPQTLAIPD | 481 | Q9Y2W3 | |
| IGLQSTIVIPFKNPT | 2756 | Q6ZTR5 | |
| IINPISGQLSVTKPL | 211 | P19022 | |
| GNPPKSNISILRVKV | 686 | P19022 | |
| SKTEIQLVQSLGVPP | 91 | P11926 | |
| LPAGQVVPKINSLSL | 431 | Q8IXS8 | |
| NAEIALRTQKTPPGL | 321 | Q9BVL2 | |
| PVKPTALTGTLQVRL | 271 | Q6P5Z2 | |
| SIGQPRKTTLSPAQL | 141 | Q8NFH5 | |
| KGLPTPQVLQRNSST | 381 | Q9BUB5 | |
| PQALVKASRSPLVTG | 1066 | Q10571 | |
| IAPSLQVITSKQRPR | 2156 | P42345 | |
| LQQLQDLRKGPPLST | 101 | Q6P0A1 | |
| ELFTTLPIVQGKSRP | 56 | P78346 | |
| PEPQLKGIVTRLFSQ | 66 | P61328 | |
| PARPVGIEKSLQLST | 1001 | P11717 | |
| QRRAPQITTPVKITL | 271 | Q16799 | |
| LIPPRSEQLVNFTGK | 176 | Q9BVX2 | |
| TPNILRIPTQVGKKA | 1266 | Q6WKZ4 | |
| SIINPPIAKIRNIGI | 61 | Q969S9 | |
| PALNTSLPQKVLGTT | 1201 | Q8TEU7 | |
| IPPSIIRSGQKQKLV | 191 | Q17R31 | |
| LKVNPTRARSGLQPQ | 681 | Q3ZLR7 | |
| RILLTGTPLQNKLPE | 876 | P51531 | |
| LQKRQGIPSKSRLPS | 381 | Q86TJ2 | |
| VIPTLGNQKPRITII | 941 | Q7Z7B0 | |
| TELIPRLKGVLTNPN | 301 | O60502 | |
| TLQLPQPEGATKKLR | 66 | Q9UJD0 | |
| LEGLRTPQLTPVRKT | 1121 | Q5VVP1 | |
| RVTQGTPQLPKALGI | 71 | Q8N3V7 | |
| KTLVGSENPPLTVIR | 771 | Q13576 | |
| VPTANPVKTNGTLLR | 141 | Q569H4 | |
| IRSLQSVGLKPIIPQ | 321 | Q16773 | |
| RLPVVLPQSTLNLAK | 36 | O95084 | |
| RPLKGNNDILSITQP | 61 | Q99707 | |
| LQRKTVQSQIGPPLT | 641 | Q96QT6 | |
| RATIKGQIQLLQPPA | 331 | Q96LK8 | |
| ILTKNLPPVLLVRGN | 1076 | Q13621 | |
| SRPIKLLQQPGTDTP | 76 | Q9BYL1 | |
| LDINRPGTVPNAKTL | 211 | Q9ULP0 | |
| PGTQVIVLSTRLLKP | 651 | Q8WU76 | |
| VLSPLIIKSTPRNLN | 401 | Q8NCN4 | |
| IKQILSTPSLIPTIQ | 431 | Q8NE31 | |
| PRSLVKPITQLLGRT | 211 | P11215 | |
| VSTGAVKLPSPQQLL | 496 | Q7Z745 | |
| SLQIRPSGNLPLATK | 216 | Q8N6T7 | |
| QPVIVSPSGTILRLK | 841 | Q5T5C0 | |
| IGPNNSNLPKIISII | 1036 | O60518 | |
| LSKVPLTQATRGPQV | 206 | Q15436 | |
| PALVLTSQKLPRAIQ | 121 | Q6PIS1 | |
| FLPVTGTLKQNIPRL | 31 | O95025 | |
| PIISRVASQIGLSQP | 76 | P78543 | |
| IQRTGLEVKPFITNP | 41 | P45381 | |
| QNGLLTPTLKAKRPE | 666 | Q9UKU0 | |
| PKAQPGDNSTRITIL | 201 | Q6V702 | |
| KILPVNLGQPFTILT | 96 | Q17RW2 | |
| SPVTPVGAQKTALRI | 851 | Q15596 | |
| LGATTPALAKLQVPR | 96 | Q6J9G0 | |
| QSSQALINIIKPPVR | 4596 | Q63HN8 | |
| LVRNGAKLSSLPQIP | 421 | Q8ND24 | |
| SPLTKQLPTLILFQG | 211 | Q9Y320 | |
| LGINLPLSIKPATQN | 971 | Q9HCE3 | |
| LSQRIIPLKKTPTSQ | 186 | Q9P2J8 | |
| VRVLQVTIPKPALST | 66 | O43361 | |
| PPLQRGKSQQLTVSA | 1066 | Q96PV0 | |
| ITDPQQLQLSPLKGL | 11 | P31350 | |
| RSPALQILLTNTKVP | 226 | Q03426 | |
| NPQKAIPVGIVASLL | 281 | P30825 | |
| GQILSKLRLASPPSQ | 51 | P01137 | |
| VPTPRLRTGLFNKIT | 86 | Q2M296 | |
| AKLEQRILSQTRGPP | 521 | O75191 | |
| KALGVSLSRPAPQIQ | 96 | P08949 | |
| LAFSVTNNVIRLKPP | 816 | Q5SRE5 | |
| VNPTVGKRNVTLPID | 1791 | Q6N022 | |
| PQKPLRNQGVVRTLS | 301 | Q9H788 | |
| GEKIPLVLSRPLSSN | 171 | O14543 | |
| PKNLLITPKDNSGRI | 1726 | Q8WWQ8 | |
| PRGLNLLPKSQTTLN | 546 | Q02763 | |
| GTLVPPSALISILQK | 41 | Q9BQ87 | |
| SLNLPVGSSQVLVPR | 286 | Q14997 | |
| VLQSLLKVQATGPPA | 666 | Q9ULM0 | |
| PSLKETTGPSRQILQ | 221 | Q8NEW0 | |
| TIQPQTARKSQLPRG | 6 | A8K0R7 | |
| RSPLLSQETAGQKPL | 6 | Q9H1Z9 | |
| NPPAGVRKIILSTNI | 676 | Q9H6S0 | |
| KVRQPQLNSLGPISA | 246 | Q6P2C0 | |
| GPILTNTNRAPEKIV | 3371 | Q7Z7G8 | |
| TGRKQSPVRIFTNIP | 351 | Q9H5U6 | |
| SLQRPLQSGIPTLVV | 521 | Q8TEC5 | |
| PRRVTNVGSLLLTPQ | 11 | O00401 | |
| KPLQLVVGTLTPSSV | 116 | Q7Z7G0 | |
| PTKAGPRQLQVLISS | 676 | Q96PF1 | |
| SGLRNILPITTAKVP | 1091 | Q5VYS8 | |
| VTIKVPAGTRLLSQP | 401 | A3KMH1 | |
| LQSLPGTVVPVRIQT | 1326 | P31629 | |
| NSTPVPLLQTTQGLK | 226 | Q14679 | |
| LPKTPRQSLSIRQTL | 1071 | Q5T5U3 | |
| SVRIPSPNILKTGLT | 2096 | Q5VUA4 | |
| NARPGQKAVLLSPVS | 266 | Q9Y493 | |
| SLKREGISQAPIPLT | 806 | Q8N5Q1 | |
| GIPQVTVNKSLLAPL | 96 | Q14CN4 | |
| LQPGNISPTSKLVSR | 311 | P24723 | |
| KTLSFPQLGVTRRPQ | 1736 | Q9NR99 | |
| KINGNPNPITTVREI | 2441 | Q9NR99 | |
| TLSGPRLPKTQLILA | 1416 | Q6PIF6 | |
| ARSQKSPPSIGIAVI | 26 | Q13224 |